André Choulika succeeds Philippe Pouletty as Chairman of France Biotech

Six new members join the Administrative Council

02-Jul-2009 - France

At the Annual General Meeting, the members of France Biotech voted to elect their governing bodies, in accordance with the organization's statutes. The newly elected Administrative Council then appointed André Choulika as Chairman. He succeeds the outgoing Chairman Philippe Pouletty MD, who had served four terms of office since 2001. Dr Pouletty was not seeking reelection and becomes an Honorary Chairman.

André Choulika PhD (aged 44 years) is CEO and founder of Cellectis, the genome engineering company that was founded in 2000. Dr. Choulika is one of the pioneers in the analysis of meganucleases and their applications in the modification of complex genomes. He obtained his doctorate in the field of molecular virology at Pierre and Marie Curie University of Paris within the laboratories of Institut Pasteur before undertaking post-doctoral research at Harvard Medical School. While working as a research fellow in the Department of Molecular Medicine at Boston Children's Hospital, he developed the background for therapeutic applications of meganucleases.

He held the position of a research fellow of Institut Pasteur from 1992 to 2006. He followed the Challenge+ courses at HEC School of Management. In addition, to his position for 9 years at Cellectis as a Director and Chief Executive Officer, he is also a member of the Supervisory Board of Viroxis SA, member of the Investment Committee of G1J Ile-de-France, member of the Council of Emerging Companies of EuropaBio and member of the Scientifique Advisory Board of Biofutur.

https://www.bionity.com/en/news/102815/andre-choulika-succeeds-philippe-pouletty-as-chairman-of-france-biotech.html